Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
A 2026 study in 3 Biotech found BPC-157 chitosan hydrogel showed promising antibacterial and drug delivery properties. Learn what the research suggests.
By Peptide Association Research Team
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel showing promising antibacterial and biocompatible properties for future biomedical use.
By Peptide Association Research Team
A 2026 study published in 3 Biotech characterized a BPC-157 chitosan hydrogel showing promising antibacterial and biocompatible properties for biomedical use.
By Peptide Association Research Team
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel showing strong encapsulation, antibacterial activity, and biocompatibility in lab testing.
By Peptide Association Research Team
A 2026 study in 3 Biotech found that a BPC-157 chitosan hydrogel showed promising antibacterial and biocompatible properties. Learn what researchers discovered.
By Peptide Association Research Team
New research on GHK-Cu peptide suggests delivery route significantly affects cognitive outcomes in aged mice. Learn what the science says and what it means for you.
By Peptide Association Research Team